Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
AD Progression Pattern Linked to Intrinsic Resistance to Aβ Toxicity
8 August 2007. There is a common pattern to the pathological progression of Alzheimer disease (AD). Neurons in the top or superficial layers of the cerebral cortex succumb first—those in the deeper layers are affected later. For decades scientists have puzzled over this phenomenon. Is it something about the location or connectivity of the deeper neurons that protects them? Or, are they inherently more resistant to pathological insults? New findings suggest that inherent resistance could explain at least some of the pattern of AD progression. Writing in today’s Journal of Neuroscience, Karl Herrup and colleagues from Case School of Medicine and the University Memory and Aging Center, both in Cleveland, Ohio, report that deep layer cortical neurons isolated from embryonic brain tissue are more resistant to Aβ toxicity than cells from the superficial strata. Figuring out what makes the deeper cells more resistant could provide new clues to tackling this devastating disease.

Testing the susceptibility of different cortical layers to Aβ is no small feat. To address this, the researchers capitalized on an observation originally made 30 years ago. Researchers studying rat hippocampal neurons found that cells which best survive the trauma of being plucked from the brain and grown in dissociated cultures are those that have most recently completed their last cell division (see Banker and Cowan, 1977). Using BrdU to label and identify recently divided neurons, first author Rita Romito-DiGiacomo and colleagues show that this is also true for mouse cortical cultures. Thus, cultures begun at embryonic day 13.5 (E13.5) predominantly comprise cells destined for the deeper layer V and VI of the cortex, while those cultured at E16.5 contain layer IV neurons as well. The authors confirmed this by showing that E13.5 cultures were devoid of cells expressing the layer IV marker RORβ but robustly stained for the T box protein Tbr1, a layer V/VI marker. Cells cultured from E16.5 embryos, on the other hand, were a mixture of Tbr1- and RORβ-positive cells, indicating that these cultures had cells from layers IV, V and VI.

Armed with this knowledge, Romito-DiGiacomo and colleagues prepared various cortical cultures from mouse embryos between embryonic day 13 and 17, then exposed them to various concentrations of Aβ42 (0 to 30 μM). They found that neurons derived earlier, that is, those destined for the deeper layers, were more resistant to toxicity. For example, after 3 days in culture with 10 μM Aβ, E13 cells were still fully viable, whereas only about 50 percent of E16 cells survived. The results indicate that neurons destined for the upper cortical layers are intrinsically more susceptible to Aβ toxicity. In support of this, the authors found that Tbr1-positive cell loss in both E13- and E16-derived cells was minimal, despite the overall loss of cells in the latter population. This finding again speaks to the robustness of the Tbr1-positive or layer V/VI cells.

Finding out why layer V/VI cells are more resistant to Aβ might prove invaluable in the fight against AD. Tbr1 itself might confer some resistance, note the authors, but there appear to be thousands of proteins that may play a potential role. Herrup and colleagues probed Aβ-treated E13.5 cultures with a gene chip array that detects 34,000+ genes. They found that expression of over 1,000 genes changed by a factor of two or more. Most were downregulated, but 45 were upregulated. They also found that in untreated cells, expression of 132 transcripts differs between E13.5- and E16.5-derived cells. Some of these proteins may hold the key to understanding the resilience of deep layer neurons to AD pathology.

One other explanation for the differential susceptibility of cortical layers to AD pathology is that neural connections may somehow influence progression. This work does not discount that incoming and outgoing connections may have some influence, but “the in vitro model suggests that there are at least some neuron-intrinsic factors that are likely to be at play in determining the pattern of neurodegeneration seen in the human AD brain,” write the authors.—Tom Fagan.

Reference:
Romito-DiGiacomo RR, Menegay H, Cicero SA, Herrup K. Effects of Alzheimer’s disease on different cortical layers: The role of intrinsic differences in Abeta susceptibility. J. Neurosci. 2007 Aug 8;27:8496-8504. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad